title: Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.
abstract: OBJECTIVE
  To examine the association between changes in glomerular filtration rates (GFR) and antiretroviral therapy (ART)-mediated suppression of plasma HIV-1 viremia.
  
  
  METHODS
  : Observational, prospective, multicenter cohort study.
  
  
  METHODS
  ART regimens or treatment strategies in HIV-1-infected subjects were implemented through randomized clinical trials; 1776 ambulatory subjects from these trials also enrolled in this cohort study.
  
  
  METHODS
  The association between suppression of viremia and GFR changes from baseline was examined using the abbreviated Modification of Diet and Renal Disease equation in mixed effects linear models.
  
  
  RESULTS
  GFR improvement was associated with ART-mediated suppression of plasma viremia in subjects with both chronic kidney disease stage > or = 2 and low baseline CD4 cell counts (< 200 cells/microl). In this subset, viral suppression (by > 1.0 log10 copies/ml or to < 400 copies/ml) was associated with an average increase in GFR of 9.2 ml/min per 1.73 m(2) from baseline (95% confidence interval, 1.6-16.8; P = 0.02) over a median follow-up of 160 weeks. The magnitude of this association increased in subjects who had greater baseline impairment of renal function, and it did not depend on race or sex.
  
  
  CONCLUSIONS
  Viral suppression was associated with GFR improvements in those with both low CD4 cell counts and impaired baseline renal function, supporting an independent contribution of HIV-1 replication to chronic renal dysfunction in advanced HIV disease. GFR improvement not associated with viral suppression also was observed in subjects with higher CD4 cell counts.
authors.affiliation: Department of Medicine, MetroHealth Medical Center, Cleveland, Ohio, USA. rkalayjian@metrohealth.org
authors.forename: Robert C
authors.initials: RC
authors.lastname: Kalayjian
authors.forename: Nora
authors.initials: N
authors.lastname: Franceschini
authors.forename: Samir K
authors.initials: SK
authors.lastname: Gupta
authors.forename: Lynda A
authors.initials: LA
authors.lastname: Szczech
authors.forename: Ezekiel
authors.initials: E
authors.lastname: Mupere
authors.forename: Ronald J
authors.initials: RJ
authors.lastname: Bosch
authors.forename: Marlene
authors.initials: M
authors.lastname: Smurzynski
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Albert
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D002908:Chronic Disease; D015331:Cohort Studies; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy* / Q000503:physiopathology; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D007674:Kidney Diseases / Q000503:physiopathology / Q000821:virology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D014766:Viremia / Q000188:drug therapy / Q000503:physiopathology; D014779:Virus Replication / Q000187:drug effects*